{"gene":"ASL","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2018,"finding":"ASL (argininosuccinate lyase) participates in the citrulline-nitric oxide (NO) cycle in neurons; ASL deficiency causes neuronal oxidative/nitrosative stress independent of hyperammonemia. Intravenous AAV8 vector delivery correcting both hepatic and cerebral ASL activity normalized NO signaling, reduced cortical cell death, and improved behavior in ASL-deficient mice, establishing that neuronal ASL activity is required for NO homeostasis in the brain.","method":"AAV8-mediated gene transfer in ASL-deficient mice, behavioral assays, neuronal cell death quantification, NO pathway biochemistry","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional rescue experiments in two age groups with multiple orthogonal readouts (behavioral, biochemical, histological) in a defined genetic model","pmids":["30158522"],"is_preprint":false},{"year":2019,"finding":"ASL is expressed in neurons of the nucleus locus coeruleus (LC) and metabolically regulates tyrosine hydroxylase (TH) activity and abundance through nitric oxide (NO) signaling. LC-specific ASL conditional knockout mice show reduced TH amount and activity, decreased catecholamine synthesis, altered stress response, and increased seizure reactivity; NO donors rescue catecholamine levels, seizure sensitivity, and stress response, placing ASL upstream of NO-mediated TH regulation.","method":"Conditional knockout mouse (LC-ASL-cKO), LC-specific TH activity and protein measurements, catecholamine quantification, NO donor pharmacological rescue, behavioral/seizure phenotyping","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific KO with pharmacological rescue and multiple biochemical readouts, published in peer-reviewed journal","pmids":["31747589"],"is_preprint":false},{"year":2021,"finding":"ASL is expressed in dopaminergic neurons of the substantia nigra pars compacta (including ALDH1A1+ subpopulation). Conditional loss of ASL in catecholamine neurons causes catecholamine deficiency, accumulation of tyrosine aggregates, elevation of α-synuclein, and motor/cognitive deficits. NO supplementation rescues aggregate formation and motor deficits, linking ASL-dependent NO production to tyrosine metabolism and neurodegeneration.","method":"Conditional knockout mouse model, immunofluorescence, catecholamine and α-synuclein measurements, NO donor rescue, behavioral testing","journal":"Human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic mouse model with pharmacological rescue and multiple biochemical/histological readouts, building on prior replicated findings","pmids":["34417872"],"is_preprint":false},{"year":2021,"finding":"ASL (argininosuccinate lyase) enzymatic activity is required for tumor suppression in clear cell renal cell carcinoma (ccRCC). Re-expression of ASL (with ASS1) suppresses growth in 2D, 3D, and xenograft models in an enzymatic-activity-dependent manner. ASL-mediated effects involve conservation of cellular aspartate (redirecting it away from pyrimidine synthesis) and regulation of nitric oxide synthesis.","method":"Loss-of-function (KO in HK-2 cells), gain-of-function re-expression in ccRCC lines, xenograft mouse models, metabolomic analysis, enzymatic activity mutants","journal":"Cancer & metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal assays (2D/3D growth, xenograft, metabolomics, activity-dead mutants) establishing enzymatic mechanism","pmids":["34861885"],"is_preprint":false},{"year":2019,"finding":"KLF7 transcriptionally activates ASL gene expression in glioma cells, and ASL in turn enhances polyamine biosynthesis (a urea cycle metabolite pathway), contributing to glioma cell proliferation, migration, and tumorigenesis.","method":"Transcriptional activation assays (luciferase/ChIP implied by 'transcriptionally activated'), functional knockdown/overexpression in glioma cells, polyamine metabolite measurements","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, transcriptional activation and functional cellular assays, but abstract lacks detail on mechanistic depth of ChIP/reporter","pmids":["31018905"],"is_preprint":false},{"year":2004,"finding":"Mutations in human adenylosuccinate lyase (ASL; EC 4.3.2.2) at positions E80D and D87E (equivalent to positions 62 and 69 in Bacillus subtilis ASL) reduce enzymatic Vmax for conversion of adenylosuccinate to AMP and fumarate and increase Km for adenylosuccinate; the D87E (position 69) mutation has modest effect while the E80D-equivalent (position 62, D→E change) causes the most drastic reduction in activity and stability, demonstrating the catalytic importance of these residues.","method":"Site-directed mutagenesis, recombinant protein expression and purification, enzyme kinetics (Vmax, Km measurements), thermal stability assay, CD spectroscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzyme reconstitution with mutagenesis and kinetic characterization in a single rigorous study","pmids":["15471876"],"is_preprint":false},{"year":2016,"finding":"Cysteamine treatment of cells expressing cysteine-for-arginine ASL mutants (p.Arg94Cys, p.Arg379Cys, p.Arg385Cys) increases ASL enzymatic activity by chemically modifying the substituted cysteine to a lysine analogue, partially restoring function; p.Arg385Cys activity after cysteamine treatment resembles the designed p.Arg385Lys mutant, providing mechanistic evidence for the cysteamine action.","method":"Mammalian expression system (293T cells), transfection of ASL cysteine-for-arginine mutants, enzyme activity assay with and without cysteamine treatment","journal":"Molecular diagnosis & therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based enzyme activity assay with mechanistic chemical rationale and multiple mutant comparisons, single lab","pmids":["26745957"],"is_preprint":false},{"year":2016,"finding":"A missense mutation c.434A>G (p.D145G) in exon 5 of the ASL gene drives alternative splicing, causing loss of exon 5 in the mRNA, as demonstrated by exon trapping assay.","method":"Next generation sequencing, exon trapping (minigene splicing assay)","journal":"BMC medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional splicing assay (exon trapping) is a direct mechanistic experiment but single lab, single method","pmids":["26843370"],"is_preprint":false},{"year":2007,"finding":"Pathogenicity of ASL splicing mutations was confirmed by functional splicing assay using a hybrid minigene. Molecular modeling using the reported 3D structure of ASL was used to predict functional consequences of missense mutations on homotetramer formation.","method":"Hybrid minigene splicing assay, molecular modeling based on ASL crystal structure, genomic DNA mutation analysis","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional splicing assay is direct experimental evidence; structural modeling is computational (Tier 4) but supports mechanistic interpretation","pmids":["17326097"],"is_preprint":false},{"year":2013,"finding":"Structural analysis of ASL mutations demonstrates that pathogenic missense variants disrupt homotetramer formation by altering bonding with neighboring residues, providing a structural mechanism for ASL deficiency.","method":"Structural considerations based on published ASL homotetramer structure, mutation mapping","journal":"Human mutation","confidence":"Low","confidence_rationale":"Tier 4 / Moderate — computational/structural modeling without experimental validation of tetramer disruption in this paper","pmids":["24166829"],"is_preprint":false},{"year":2019,"finding":"Structural examination of four novel pathogenic ASL variants (Leu260Arg, Ser447Thr, Arg146Gly, Leu199Val) revealed that all affect stability of the tetrameric ASL structure by disturbing bonding with neighboring residues.","method":"In silico structural analysis of ASL tetramer model","journal":"Molecular genetics and metabolism reports","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational structural prediction only, no experimental validation of tetramer disruption","pmids":["31709144"],"is_preprint":false},{"year":2023,"finding":"ASL-encoding mRNA formulated in lipid nanoparticles (LNP) produces robust ASL protein expression in vitro and in vivo, and intravenous administration in ASLNeo/Neo mice (ASLD model) drastically improves survival, demonstrating that restored ASL enzymatic activity in hepatocytes is sufficient to correct the metabolic deficit.","method":"mRNA-LNP formulation, in vitro expression in human cells, IV administration in ASLNeo/Neo mouse model, survival assay, cytokine profiling","journal":"Biomedicines","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo functional rescue with defined genetic model and multiple dose groups, single lab","pmids":["37371829"],"is_preprint":false},{"year":2019,"finding":"ASL enzymatic activity is required for its tumor-suppressive function in ccRCC; catalytically inactive ASL mutants do not suppress growth, establishing that the lyase catalytic activity (cleaving argininosuccinate to arginine and fumarate) rather than a structural/scaffold role mediates growth suppression.","method":"Expression of enzymatic activity mutants in ccRCC cell lines, 2D/3D growth assays, xenograft models","journal":"Cancer & metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — activity-dead mutant rescue experiment directly tests catalytic requirement, with in vivo validation","pmids":["34861885"],"is_preprint":false},{"year":2026,"finding":"Taurine suppresses urea cycle activity by targeting ASL as its main effector in hepatocellular carcinoma (HCC) cells. FOS proto-oncogene functions as a transcription factor for ASL; taurine treatment reduces FOS levels, thereby suppressing ASL expression and urea cycle activity. The FOS-ASL axis is required for the metabolic effects of taurine on HCC tumor growth.","method":"Target identification (ASL identified as taurine's main target), transcription factor analysis (FOS-ASL axis), knockdown/overexpression in HCC cell lines, metabolic assays, tumor growth assays","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — cell-based mechanistic assays with transcriptional regulation and functional rescue, but abstract lacks structural/biochemical detail of direct taurine-ASL interaction","pmids":["41708583"],"is_preprint":false},{"year":2002,"finding":"The complete ASL gene structure was determined, comprising 16 coding exons, enabling systematic mutation analysis. Mutational hotspots were identified in exons 4, 5, and 7, and a predominant splicing mutation IVS5+1G→A was found on 15 alleles, establishing the genomic architecture of ASL deficiency.","method":"Genomic DNA sequencing, PCR-based mutation screening of all 16 coding exons, identification of transcript variants","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — comprehensive gene structure determination with mutation-disease correlation across 27 patients, single study","pmids":["12384776"],"is_preprint":false},{"year":2019,"finding":"Novel ASL mutation c.206A>G (p.Lys69Arg) significantly reduces ASL enzymatic activity when expressed in HEK293T cells, while the p.Arg213* nonsense mutation abolishes activity entirely, confirming pathogenicity and establishing the functional importance of these residues.","method":"Expression of ASL constructs in HEK293T cells, spectrophotometric coupled enzyme assay measuring urea production","journal":"BioMed research international","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct enzyme activity assay in mammalian expression system, single lab, single method","pmids":["31183366"],"is_preprint":false}],"current_model":"Argininosuccinate lyase (ASL) is a homotetrameric enzyme that catalyzes the cleavage of argininosuccinate to arginine and fumarate, functioning both in the hepatic urea cycle (detoxifying ammonia) and in the citrulline-nitric oxide (NO) cycle in extrahepatic tissues including neurons; its catalytic activity is required for NO production via the arginine-NOS pathway, and through this mechanism ASL regulates tyrosine hydroxylase activity and catecholamine biosynthesis in locus coeruleus and substantia nigra neurons, while in cancer contexts ASL enzymatic activity controls aspartate utilization, pyrimidine biosynthesis, and nitric oxide levels to suppress tumor growth."},"narrative":{"mechanistic_narrative":"Argininosuccinate lyase (ASL) is a homotetrameric urea-cycle enzyme whose lyase activity cleaves argininosuccinate to arginine and fumarate, and which serves a broader role in supplying arginine for nitric oxide (NO) production through the citrulline-NO cycle [PMID:30158522, PMID:34861885]. Beyond hepatic ammonia detoxification, neuronal ASL is required for brain NO homeostasis: loss of ASL produces nitrosative/oxidative stress independent of hyperammonemia, and combined hepatic plus cerebral correction normalizes NO signaling and rescues neuronal cell death and behavior [PMID:30158522]. Through this NO-generating function ASL governs catecholamine biosynthesis in specific brainstem nuclei—it controls tyrosine hydroxylase abundance and activity in locus coeruleus neurons and, in substantia nigra dopaminergic neurons, restrains tyrosine aggregation and α-synuclein elevation, with NO donors rescuing the catecholamine and motor phenotypes in conditional knockouts [PMID:31747589, PMID:34417872]. In cancer, ASL acts as an enzymatic-activity-dependent tumor suppressor in clear cell renal cell carcinoma, where it conserves cellular aspartate away from pyrimidine synthesis and modulates NO levels; catalytically dead mutants fail to suppress growth, establishing that lyase catalysis rather than a scaffolding role is responsible [PMID:34861885]. ASL expression is itself transcriptionally tuned by upstream regulators, including KLF7 in glioma and a taurine-responsive FOS-ASL axis in hepatocellular carcinoma, linking ASL activity to polyamine biosynthesis and urea-cycle-driven proliferation in tumor contexts [PMID:31018905, PMID:41708583]. Loss-of-function mutations cause ASL deficiency: the gene comprises 16 coding exons with mutational hotspots and a predominant splicing variant, and pathogenic missense and splice mutations reduce or abolish enzymatic activity, frequently by disrupting homotetramer assembly [PMID:12384776, PMID:31183366, PMID:26843370].","teleology":[{"year":2002,"claim":"Establishing the genomic architecture of ASL was needed to interpret disease alleles systematically; defining all 16 coding exons and recurrent mutations provided the framework for ASL deficiency genetics.","evidence":"Genomic DNA sequencing and mutation screening across 27 patients","pmids":["12384776"],"confidence":"Medium","gaps":["Gene structure alone does not establish functional consequence of individual variants","No enzymatic or structural readout for the catalogued mutations"]},{"year":2004,"claim":"To define which residues are catalytically essential, kinetic dissection of point mutations showed specific positions are required for substrate turnover and protein stability.","evidence":"Site-directed mutagenesis, recombinant enzyme kinetics, thermal stability and CD spectroscopy","pmids":["15471876"],"confidence":"High","gaps":["Performed on a lyase-family context (adenylosuccinate lyase residues) rather than full human urea-cycle catalysis","Does not address tetramer-level interactions in the cellular setting"]},{"year":2007,"claim":"To distinguish coding from splicing pathogenicity and predict missense impact, functional minigene assays plus structural mapping connected variants to tetramer disruption.","evidence":"Hybrid minigene splicing assay and molecular modeling on the ASL crystal structure","pmids":["17326097"],"confidence":"Medium","gaps":["Structural modeling is computational, not experimentally validated for tetramer disruption","Single assay per variant class"]},{"year":2013,"claim":"Extending the structural rationale, mutation mapping argued that pathogenic missense variants disrupt homotetramer formation, offering a unifying structural mechanism for deficiency.","evidence":"Structural mapping onto the published ASL homotetramer","pmids":["24166829"],"confidence":"Low","gaps":["Computational only; no experimental validation of tetramer disruption in this study","Does not quantify residual enzymatic activity"]},{"year":2016,"claim":"To determine whether ASL deficiency could be chemically corrected, cysteamine was shown to chemically convert cysteine-substituted residues toward a lysine analogue and partially restore activity, providing a mechanistic rationale for pharmacochaperone-style rescue.","evidence":"Expression of cysteine-for-arginine ASL mutants in 293T cells with cysteamine treatment and activity assays","pmids":["26745957"],"confidence":"Medium","gaps":["Single lab, cell-based activity readout","Applies only to specific arginine-to-cysteine substitutions"]},{"year":2016,"claim":"To explain why a coding missense variant behaves as a loss-of-function allele, an exon-trapping assay revealed that c.434A>G causes exon 5 skipping, demonstrating a splicing mechanism beyond simple amino-acid change.","evidence":"Exon trapping minigene splicing assay following NGS","pmids":["26843370"],"confidence":"Medium","gaps":["Single method, single variant","No protein-level or enzymatic quantification of the resulting transcript"]},{"year":2018,"claim":"Whether ASL has a brain-intrinsic role beyond hepatic ammonia clearance was unresolved; combined hepatic and cerebral gene correction established that neuronal ASL activity is required for NO homeostasis and prevents nitrosative-stress-driven neuronal death independent of hyperammonemia.","evidence":"AAV8 gene transfer in ASL-deficient mice with behavioral, biochemical, and histological readouts","pmids":["30158522"],"confidence":"High","gaps":["Does not map which neuronal populations require ASL most acutely","NO source apportionment between cell types not resolved"]},{"year":2019,"claim":"To define a specific neuronal output of ASL-dependent NO, locus-coeruleus-specific knockout placed ASL upstream of NO-mediated regulation of tyrosine hydroxylase and catecholamine synthesis, with NO donors rescuing the phenotype.","evidence":"LC-specific conditional knockout mouse, TH activity/abundance measurements, catecholamine quantification, NO donor rescue, seizure/stress phenotyping","pmids":["31747589"],"confidence":"High","gaps":["Molecular link between NO and TH abundance not fully defined","Generalization to other catecholaminergic nuclei addressed only later"]},{"year":2019,"claim":"To determine whether ASL contributes to tumor biology and how, work showed KLF7 transcriptionally activates ASL in glioma and that ASL enhances polyamine biosynthesis to drive proliferation and migration.","evidence":"Transcriptional activation assays and knockdown/overexpression in glioma cells with polyamine metabolite measurement","pmids":["31018905"],"confidence":"Medium","gaps":["Depth of ChIP/reporter evidence for direct KLF7 binding limited","Single lab"]},{"year":2019,"claim":"Additional patient variants were functionally tested to confirm pathogenicity, showing p.Lys69Arg reduces and p.Arg213* abolishes enzymatic activity in a cellular system.","evidence":"Expression in HEK293T cells with spectrophotometric coupled enzyme assay measuring urea production","pmids":["31183366"],"confidence":"Medium","gaps":["Single method, single lab","No structural correlate for the activity loss"]},{"year":2019,"claim":"Whether reported missense variants act through folding/assembly was addressed by in silico tetramer analysis predicting that four novel variants destabilize the tetramer.","evidence":"In silico structural analysis of the ASL tetramer model","pmids":["31709144"],"confidence":"Low","gaps":["Computational prediction only, no experimental tetramer or activity validation","Variant-specific residual function unquantified"]},{"year":2021,"claim":"To extend the catecholaminergic role to dopaminergic neurodegeneration, conditional ASL loss in catecholamine neurons produced tyrosine aggregates, α-synuclein elevation, and motor/cognitive deficits, all rescued by NO supplementation.","evidence":"Conditional knockout mouse, immunofluorescence, catecholamine and α-synuclein measurement, NO donor rescue, behavioral testing","pmids":["34417872"],"confidence":"High","gaps":["Mechanistic link between NO loss and tyrosine aggregation not molecularly resolved","Relevance to idiopathic Parkinsonian pathology not established"]},{"year":2021,"claim":"To test whether ASL acts as a tumor suppressor through catalysis or scaffolding, re-expression with activity-dead mutants showed enzymatic activity is required for growth suppression in ccRCC, acting via aspartate conservation away from pyrimidine synthesis and NO regulation.","evidence":"Loss- and gain-of-function in ccRCC lines, xenografts, metabolomics, and catalytically inactive mutants","pmids":["34861885"],"confidence":"High","gaps":["Relative contribution of aspartate conservation versus NO not fully partitioned","Context-specificity across tumor types not defined"]},{"year":2023,"claim":"To establish therapeutic sufficiency of restoring ASL, mRNA-LNP delivery produced robust hepatocyte ASL expression and drastically improved survival in an ASL deficiency mouse model.","evidence":"mRNA-LNP formulation, in vitro expression, IV administration in ASLNeo/Neo mice, survival and cytokine profiling","pmids":["37371829"],"confidence":"Medium","gaps":["Hepatic restoration may not address cerebral NO/catecholamine phenotypes","Durability and repeat-dosing tolerability not fully characterized"]},{"year":2026,"claim":"To identify how metabolic signals tune ASL in cancer, taurine was shown to act through a FOS-ASL transcriptional axis to suppress urea cycle activity and HCC tumor growth.","evidence":"Target identification, FOS-ASL transcription analysis, knockdown/overexpression in HCC lines, metabolic and tumor growth assays","pmids":["41708583"],"confidence":"Medium","gaps":["Direct physical taurine-ASL interaction not biochemically demonstrated","Single mechanistic context (HCC)"]},{"year":null,"claim":"How ASL-dependent NO generation is biochemically coupled to tyrosine hydroxylase abundance and tyrosine aggregation, and how its catalytic versus metabolite-channeling roles are partitioned across hepatic, neuronal, and tumor contexts, remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No molecular mechanism connecting NO levels to TH protein stability","No reconciliation of ASL as urea-cycle enzyme versus NO-cycle effector at the structural level","Tumor-context dependence (suppressor in ccRCC, proliferative in glioma/HCC) mechanistically unexplained"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016829","term_label":"lyase activity","supporting_discovery_ids":[3,12]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[5,15]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[8,9,10]}],"localization":[],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,3,11,13]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[3,14,15]}],"complexes":["ASL homotetramer"],"partners":["ASS1","KLF7","FOS"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P04424","full_name":"Argininosuccinate lyase","aliases":["Arginosuccinase"],"length_aa":464,"mass_kda":51.7,"function":"Catalyzes the reversible cleavage of L-argininosuccinate to fumarate and L-arginine, an intermediate step reaction in the urea cycle mostly providing for hepatic nitrogen detoxification into excretable urea as well as de novo L-arginine synthesis in nonhepatic tissues (PubMed:11747432, PubMed:11747433, PubMed:22081021, PubMed:2263616, PubMed:9045711). Essential regulator of intracellular and extracellular L-arginine pools. As part of citrulline-nitric oxide cycle, forms tissue-specific multiprotein complexes with argininosuccinate synthase ASS1, transport protein SLC7A1 and nitric oxide synthase NOS1, NOS2 or NOS3, allowing for cell-autonomous L-arginine synthesis while channeling extracellular L-arginine to nitric oxide synthesis pathway (PubMed:22081021)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P04424/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ASL","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ASL","total_profiled":1310},"omim":[{"mim_id":"620969","title":"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IVb; CDAN4B","url":"https://www.omim.org/entry/620969"},{"mim_id":"620657","title":"AMYLOIDOSIS, HEREDITARY SYSTEMIC 3; AMYLD3","url":"https://www.omim.org/entry/620657"},{"mim_id":"620192","title":"LACRIMOAURICULODENTODIGITAL SYNDROME 2; LADD2","url":"https://www.omim.org/entry/620192"},{"mim_id":"619562","title":"JOUBERT SYNDROME 39; JBTS39","url":"https://www.omim.org/entry/619562"},{"mim_id":"619285","title":"TRANSMEMBRANE PROTEIN 218; TMEM218","url":"https://www.omim.org/entry/619285"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":356.0}],"url":"https://www.proteinatlas.org/search/ASL"},"hgnc":{"alias_symbol":["ASAL"],"prev_symbol":[]},"alphafold":{"accession":"P04424","domains":[{"cath_id":"1.10.275.10","chopping":"18-105","consensus_level":"high","plddt":97.0298,"start":18,"end":105},{"cath_id":"1.20.200.10","chopping":"112-362","consensus_level":"medium","plddt":98.2586,"start":112,"end":362}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P04424","model_url":"https://alphafold.ebi.ac.uk/files/AF-P04424-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P04424-F1-predicted_aligned_error_v6.png","plddt_mean":96.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ASL","jax_strain_url":"https://www.jax.org/strain/search?query=ASL"},"sequence":{"accession":"P04424","fasta_url":"https://rest.uniprot.org/uniprotkb/P04424.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P04424/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P04424"}},"corpus_meta":[{"pmid":"32329881","id":"PMC_32329881","title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32329881","citation_count":290,"is_preprint":false},{"pmid":"6193366","id":"PMC_6193366","title":"Pharmacology of ASL-8052, a novel beta-adrenergic receptor antagonist with an ultrashort duration of action.","date":"1983","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/6193366","citation_count":76,"is_preprint":false},{"pmid":"15653293","id":"PMC_15653293","title":"Neural organization for recognition of grammatical and emotional facial expressions in deaf ASL signers and hearing nonsigners.","date":"2005","source":"Brain research. Cognitive brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15653293","citation_count":65,"is_preprint":false},{"pmid":"15579849","id":"PMC_15579849","title":"Face processing by deaf ASL signers: evidence for expertise in distinguished local features.","date":"1997","source":"Journal of deaf studies and deaf education","url":"https://pubmed.ncbi.nlm.nih.gov/15579849","citation_count":63,"is_preprint":false},{"pmid":"28488024","id":"PMC_28488024","title":"Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion.","date":"2017","source":"Clinical neuroradiology","url":"https://pubmed.ncbi.nlm.nih.gov/28488024","citation_count":57,"is_preprint":false},{"pmid":"17147631","id":"PMC_17147631","title":"The efficacy of a novel insecticidal protein, Allium sativum leaf lectin (ASAL), against homopteran insects monitored in transgenic tobacco.","date":"2005","source":"Plant biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/17147631","citation_count":47,"is_preprint":false},{"pmid":"17326097","id":"PMC_17326097","title":"Argininosuccinate lyase deficiency: mutational spectrum in Italian patients and identification of a novel ASL pseudogene.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17326097","citation_count":42,"is_preprint":false},{"pmid":"19184504","id":"PMC_19184504","title":"Tissue specific expression of potent insecticidal, Allium sativum leaf agglutinin (ASAL) in important pulse crop, chickpea (Cicer arietinum L.) to resist the phloem feeding Aphis craccivora.","date":"2009","source":"Transgenic research","url":"https://pubmed.ncbi.nlm.nih.gov/19184504","citation_count":41,"is_preprint":false},{"pmid":"23112232","id":"PMC_23112232","title":"ASL/LBD phylogeny suggests that genetic mechanisms of root initiation downstream of auxin are distinct in lycophytes and euphyllophytes.","date":"2012","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/23112232","citation_count":40,"is_preprint":false},{"pmid":"30158522","id":"PMC_30158522","title":"Argininosuccinic aciduria fosters neuronal nitrosative stress reversed by Asl gene transfer.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30158522","citation_count":38,"is_preprint":false},{"pmid":"18854007","id":"PMC_18854007","title":"Transgenic rice expressing Allium sativum leaf agglutinin (ASAL) exhibits high-level resistance against major sap-sucking pests.","date":"2008","source":"BMC plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/18854007","citation_count":37,"is_preprint":false},{"pmid":"24166829","id":"PMC_24166829","title":"Mutations and polymorphisms in the human argininosuccinate lyase (ASL) gene.","date":"2013","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/24166829","citation_count":37,"is_preprint":false},{"pmid":"31018905","id":"PMC_31018905","title":"KLF7 promotes polyamine biosynthesis and glioma development through transcriptionally activating ASL.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31018905","citation_count":35,"is_preprint":false},{"pmid":"29845640","id":"PMC_29845640","title":"CEST, ASL, and magnetization transfer contrast: How similar pulse sequences detect different phenomena.","date":"2018","source":"Magnetic resonance in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29845640","citation_count":33,"is_preprint":false},{"pmid":"21547727","id":"PMC_21547727","title":"Methods for ASL measurements and mucus transport rates in cell cultures.","date":"2011","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/21547727","citation_count":33,"is_preprint":false},{"pmid":"12384776","id":"PMC_12384776","title":"Argininosuccinate lyase (ASL) deficiency: mutation analysis in 27 patients and a completed structure of the human ASL gene.","date":"2002","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12384776","citation_count":33,"is_preprint":false},{"pmid":"32910547","id":"PMC_32910547","title":"Increased blood-brain barrier permeability to water in the aging brain detected using noninvasive multi-TE ASL MRI.","date":"2020","source":"Magnetic resonance in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32910547","citation_count":31,"is_preprint":false},{"pmid":"34861885","id":"PMC_34861885","title":"ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism.","date":"2021","source":"Cancer & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34861885","citation_count":30,"is_preprint":false},{"pmid":"31747589","id":"PMC_31747589","title":"ASL Metabolically Regulates Tyrosine Hydroxylase in the Nucleus Locus Coeruleus.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31747589","citation_count":27,"is_preprint":false},{"pmid":"2029731","id":"PMC_2029731","title":"Cortisol induces rapid accumulation of whey acid protein mRNA but not of asl and b-casein mRNA in rabbit mammary explants.","date":"1991","source":"Cell biology international reports","url":"https://pubmed.ncbi.nlm.nih.gov/2029731","citation_count":27,"is_preprint":false},{"pmid":"8733568","id":"PMC_8733568","title":"Competition on the face: affect and language in ASL motherese.","date":"1996","source":"Journal of child language","url":"https://pubmed.ncbi.nlm.nih.gov/8733568","citation_count":25,"is_preprint":false},{"pmid":"6140172","id":"PMC_6140172","title":"Cardiovascular pharmacology of ASL-8052, an ultra-short acting beta blocker.","date":"1983","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/6140172","citation_count":25,"is_preprint":false},{"pmid":"22240319","id":"PMC_22240319","title":"The Neurospora crassa OS MAPK pathway-activated transcription factor ASL-1 contributes to circadian rhythms in pathway responsive clock-controlled genes.","date":"2012","source":"Fungal genetics and biology : FG & B","url":"https://pubmed.ncbi.nlm.nih.gov/22240319","citation_count":24,"is_preprint":false},{"pmid":"6084788","id":"PMC_6084788","title":"Beta-blocking and hemodynamic effects of ASL-8052.","date":"1984","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/6084788","citation_count":24,"is_preprint":false},{"pmid":"24355805","id":"PMC_24355805","title":"Synthetic fusion-protein containing domains of Bt Cry1Ac and Allium sativum lectin (ASAL) conferred enhanced insecticidal activity against major lepidopteran pests.","date":"2013","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/24355805","citation_count":22,"is_preprint":false},{"pmid":"10767990","id":"PMC_10767990","title":"Stress in ASL: empirical evidence and linguistic issues.","date":"1999","source":"Language and speech","url":"https://pubmed.ncbi.nlm.nih.gov/10767990","citation_count":20,"is_preprint":false},{"pmid":"30077647","id":"PMC_30077647","title":"Multifaceted assessment of the APP/PS1 mouse model for Alzheimer's disease: Applying MRS, DTI, and ASL.","date":"2018","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/30077647","citation_count":19,"is_preprint":false},{"pmid":"15471876","id":"PMC_15471876","title":"Two novel mutant human adenylosuccinate lyases (ASLs) associated with autism and characterization of the equivalent mutant Bacillus subtilis ASL.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15471876","citation_count":19,"is_preprint":false},{"pmid":"22182469","id":"PMC_22182469","title":"Molecular modeling of Bt Cry1Ac (DI-DII)-ASAL (Allium sativum lectin)-fusion protein and its interaction with aminopeptidase N (APN) receptor of Manduca sexta.","date":"2011","source":"Journal of molecular graphics & modelling","url":"https://pubmed.ncbi.nlm.nih.gov/22182469","citation_count":18,"is_preprint":false},{"pmid":"24023750","id":"PMC_24023750","title":"Development of transgenic cotton lines expressing Allium sativum agglutinin (ASAL) for enhanced resistance against major sap-sucking pests.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24023750","citation_count":18,"is_preprint":false},{"pmid":"23296186","id":"PMC_23296186","title":"Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI.","date":"2013","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/23296186","citation_count":18,"is_preprint":false},{"pmid":"21416402","id":"PMC_21416402","title":"Pyramiding of Ryd2 and Ryd3 conferring tolerance to a German isolate of Barley yellow dwarf virus-PAV (BYDV-PAV-ASL-1) leads to quantitative resistance against this isolate.","date":"2011","source":"TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik","url":"https://pubmed.ncbi.nlm.nih.gov/21416402","citation_count":18,"is_preprint":false},{"pmid":"21295625","id":"PMC_21295625","title":"Pyramided rice lines harbouring Allium sativum (asal) and Galanthus nivalis (gna) lectin genes impart enhanced resistance against major sap-sucking pests.","date":"2011","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/21295625","citation_count":17,"is_preprint":false},{"pmid":"34417872","id":"PMC_34417872","title":"ASL expression in ALDH1A1+ neurons in the substantia nigra metabolically contributes to neurodegenerative phenotype.","date":"2021","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34417872","citation_count":17,"is_preprint":false},{"pmid":"31039618","id":"PMC_31039618","title":"Thermostability enhancement of the α-carbonic anhydrase from Sulfurihydrogenibium yellowstonense by using the anchoring-and-self-labelling-protein-tag system (ASLtag).","date":"2019","source":"Journal of enzyme inhibition and medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31039618","citation_count":17,"is_preprint":false},{"pmid":"27068181","id":"PMC_27068181","title":"Glial fibrillary acidic protein (GFAP) immunoreactivity correlates with cortical perfusion parameters determined by bolus tracking arterial spin labelling (bt-ASL) magnetic resonance (MR) imaging in the Wistar Kyoto rat.","date":"2016","source":"Physiology & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/27068181","citation_count":17,"is_preprint":false},{"pmid":"29855556","id":"PMC_29855556","title":"Expression of hybrid fusion protein (Cry1Ac::ASAL) in transgenic rice plants imparts resistance against multiple insect pests.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29855556","citation_count":14,"is_preprint":false},{"pmid":"36183361","id":"PMC_36183361","title":"The SLC26A9 inhibitor S9-A13 provides no evidence for a role of SLC26A9 in airway chloride secretion but suggests a contribution to regulation of ASL pH and gastric proton secretion.","date":"2022","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/36183361","citation_count":14,"is_preprint":false},{"pmid":"9812171","id":"PMC_9812171","title":"Determination of p185 and adenylosuccinate lyase (ASL) activity in preneoplastic colon lesions and intestinal mucosa of human subjects.","date":"1998","source":"Clinical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9812171","citation_count":11,"is_preprint":false},{"pmid":"1027145","id":"PMC_1027145","title":"The effect of specific antiserum on the metabolism of three membrane-associated antigens of ASL-1 x LM(TK)- hybrid cells.","date":"1976","source":"Somatic cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1027145","citation_count":10,"is_preprint":false},{"pmid":"37371829","id":"PMC_37371829","title":"ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model.","date":"2023","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/37371829","citation_count":8,"is_preprint":false},{"pmid":"24920128","id":"PMC_24920128","title":"Comparing segmented ASL perfusion of vascular territories using manual versus semiautomated techniques in children with sickle cell anemia.","date":"2014","source":"Journal of magnetic resonance imaging : JMRI","url":"https://pubmed.ncbi.nlm.nih.gov/24920128","citation_count":8,"is_preprint":false},{"pmid":"7120130","id":"PMC_7120130","title":"Cardiovascular pharmacology of ASL-7022, a novel catecholamine. I. Inotropic, chronotropic and pressor actions.","date":"1982","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/7120130","citation_count":8,"is_preprint":false},{"pmid":"37474568","id":"PMC_37474568","title":"Molecular-enriched functional connectivity in the human brain using multiband multi-echo simultaneous ASL/BOLD fMRI.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37474568","citation_count":7,"is_preprint":false},{"pmid":"31410924","id":"PMC_31410924","title":"Pancreatic perfusion modulation following glucose stimulation assessed by noninvasive arterial spin labeling (ASL) MRI.","date":"2019","source":"Journal of magnetic resonance imaging : JMRI","url":"https://pubmed.ncbi.nlm.nih.gov/31410924","citation_count":6,"is_preprint":false},{"pmid":"26843370","id":"PMC_26843370","title":"NGS in argininosuccinic aciduria detects a mutation (D145G) which drives alternative splicing of ASL: a case report study.","date":"2016","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26843370","citation_count":6,"is_preprint":false},{"pmid":"26745957","id":"PMC_26745957","title":"Effect of Cysteamine on Mutant ASL Proteins with Cysteine for Arginine Substitutions.","date":"2016","source":"Molecular diagnosis & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/26745957","citation_count":5,"is_preprint":false},{"pmid":"37901133","id":"PMC_37901133","title":"Utilizing Reduced Labeled Proton Clearance to Identify Preclinical Alzheimer Disease with 3D ASL MRI.","date":"2023","source":"Case reports in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37901133","citation_count":5,"is_preprint":false},{"pmid":"24927999","id":"PMC_24927999","title":"[Genetic analysis of ASS1, ASL and SLC25A13 in citrullinemia patients].","date":"2014","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24927999","citation_count":4,"is_preprint":false},{"pmid":"39648073","id":"PMC_39648073","title":"Alterations in hippocampal somatostatin interneurons, GABAergic metabolism, and ASL perfusion in an aged male mouse model of POCD aggravated by sleep fragmentation.","date":"2024","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/39648073","citation_count":4,"is_preprint":false},{"pmid":"31328310","id":"PMC_31328310","title":"Chemical Synthesis of Oligoribonucleotide (ASL of tRNALys T. brucei) Containing a Recently Discovered Cyclic Form of 2-Methylthio-N6 -threonylcarbamoyladenosine (ms2 ct6 A).","date":"2019","source":"Chemistry (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/31328310","citation_count":4,"is_preprint":false},{"pmid":"37335404","id":"PMC_37335404","title":"Application study of DTI combined with ASL in the crossed cerebellar diaschisis after subacute cerebral hemorrhage.","date":"2023","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/37335404","citation_count":3,"is_preprint":false},{"pmid":"31709144","id":"PMC_31709144","title":"Identification of mutations in Malaysian patients with argininosuccinate lyase (ASL) deficiency.","date":"2019","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/31709144","citation_count":3,"is_preprint":false},{"pmid":"28981931","id":"PMC_28981931","title":"[Mutational analysis of ASS1, ASL and SLC25A13 genes in six Chinese patients with citrullinemia].","date":"2017","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28981931","citation_count":3,"is_preprint":false},{"pmid":"38592052","id":"PMC_38592052","title":"Identification of Novel and Recurrent Variants in BTD, GBE1, AGL and ASL Genes in Families with Metabolic Disorders in Saudi Arabia.","date":"2024","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38592052","citation_count":2,"is_preprint":false},{"pmid":"36833389","id":"PMC_36833389","title":"ThrRS-Mediated Translation Regulation of the RNA Polymerase III Subunit RPC10 Occurs through an Element with Similarity to Cognate tRNA ASL and Affects tRNA Levels.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36833389","citation_count":2,"is_preprint":false},{"pmid":"489968","id":"PMC_489968","title":"Inhibition of growth of ASL-1w murine leukemia cells by anti-thymus leukemia antigen (TL) serum in the absence of complement.","date":"1979","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/489968","citation_count":2,"is_preprint":false},{"pmid":"40841161","id":"PMC_40841161","title":"Similarity of Biological Information Captured by [68]Ga-PSMA-11 PET and ASL Perfusion MRI in Glioblastoma.","date":"2026","source":"AJNR. American journal of neuroradiology","url":"https://pubmed.ncbi.nlm.nih.gov/40841161","citation_count":1,"is_preprint":false},{"pmid":"25002880","id":"PMC_25002880","title":"Paget's disease population analysis within Rheumatology Outpatient of the ASL of Biella (Piedmont Region, Italy).","date":"2014","source":"Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases","url":"https://pubmed.ncbi.nlm.nih.gov/25002880","citation_count":1,"is_preprint":false},{"pmid":"11149266","id":"PMC_11149266","title":"[Rare cause of tachy-, asl well asl bradycardic arrhythmias].","date":"2000","source":"Zeitschrift fur Kardiologie","url":"https://pubmed.ncbi.nlm.nih.gov/11149266","citation_count":1,"is_preprint":false},{"pmid":"18590049","id":"PMC_18590049","title":"[Managing waiting lists outpatients clinic. An experience in ASL 4--Turin].","date":"2008","source":"Annali di igiene : medicina preventiva e di comunita","url":"https://pubmed.ncbi.nlm.nih.gov/18590049","citation_count":1,"is_preprint":false},{"pmid":"40107877","id":"PMC_40107877","title":"Looking at Viewpoint in ASL Through a Cognitive Linguistics Lens.","date":"2025","source":"Wiley interdisciplinary reviews. Cognitive science","url":"https://pubmed.ncbi.nlm.nih.gov/40107877","citation_count":0,"is_preprint":false},{"pmid":"41708583","id":"PMC_41708583","title":"Taurine is a natural suppressor of urea cycle via targeting ASL.","date":"2026","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/41708583","citation_count":0,"is_preprint":false},{"pmid":"37571525","id":"PMC_37571525","title":"Research on Wind Turbine Fault Detection Based on the Fusion of ASL-CatBoost and TtRSA.","date":"2023","source":"Sensors (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/37571525","citation_count":0,"is_preprint":false},{"pmid":"40864487","id":"PMC_40864487","title":"[Telemonitoring in heart failure: methodology and results of ASL Nuoro's 2-year experience].","date":"2025","source":"Giornale italiano di cardiologia (2006)","url":"https://pubmed.ncbi.nlm.nih.gov/40864487","citation_count":0,"is_preprint":false},{"pmid":"31183366","id":"PMC_31183366","title":"Whole-Exome Sequencing Identified a Novel Compound Heterozygous Genotype in ASL in a Chinese Han Patient with Argininosuccinate Lyase Deficiency.","date":"2019","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/31183366","citation_count":0,"is_preprint":false},{"pmid":"41174115","id":"PMC_41174115","title":"Screening of targets related to amino acid metabolism in glioma to identify the tumor-promoting effects of its core gene ASL.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41174115","citation_count":0,"is_preprint":false},{"pmid":"41568633","id":"PMC_41568633","title":"[Hospital-territory integration: the case of the Territorial Oncology Center of the ASL 04 of Teramo].","date":"2026","source":"Recenti progressi in medicina","url":"https://pubmed.ncbi.nlm.nih.gov/41568633","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":33711,"output_tokens":3790,"usd":0.078992,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11781,"output_tokens":4562,"usd":0.086477,"stage2_stop_reason":"end_turn"},"total_usd":0.165469,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"ASL (argininosuccinate lyase) participates in the citrulline-nitric oxide (NO) cycle in neurons; ASL deficiency causes neuronal oxidative/nitrosative stress independent of hyperammonemia. Intravenous AAV8 vector delivery correcting both hepatic and cerebral ASL activity normalized NO signaling, reduced cortical cell death, and improved behavior in ASL-deficient mice, establishing that neuronal ASL activity is required for NO homeostasis in the brain.\",\n      \"method\": \"AAV8-mediated gene transfer in ASL-deficient mice, behavioral assays, neuronal cell death quantification, NO pathway biochemistry\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional rescue experiments in two age groups with multiple orthogonal readouts (behavioral, biochemical, histological) in a defined genetic model\",\n      \"pmids\": [\"30158522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ASL is expressed in neurons of the nucleus locus coeruleus (LC) and metabolically regulates tyrosine hydroxylase (TH) activity and abundance through nitric oxide (NO) signaling. LC-specific ASL conditional knockout mice show reduced TH amount and activity, decreased catecholamine synthesis, altered stress response, and increased seizure reactivity; NO donors rescue catecholamine levels, seizure sensitivity, and stress response, placing ASL upstream of NO-mediated TH regulation.\",\n      \"method\": \"Conditional knockout mouse (LC-ASL-cKO), LC-specific TH activity and protein measurements, catecholamine quantification, NO donor pharmacological rescue, behavioral/seizure phenotyping\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific KO with pharmacological rescue and multiple biochemical readouts, published in peer-reviewed journal\",\n      \"pmids\": [\"31747589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ASL is expressed in dopaminergic neurons of the substantia nigra pars compacta (including ALDH1A1+ subpopulation). Conditional loss of ASL in catecholamine neurons causes catecholamine deficiency, accumulation of tyrosine aggregates, elevation of α-synuclein, and motor/cognitive deficits. NO supplementation rescues aggregate formation and motor deficits, linking ASL-dependent NO production to tyrosine metabolism and neurodegeneration.\",\n      \"method\": \"Conditional knockout mouse model, immunofluorescence, catecholamine and α-synuclein measurements, NO donor rescue, behavioral testing\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic mouse model with pharmacological rescue and multiple biochemical/histological readouts, building on prior replicated findings\",\n      \"pmids\": [\"34417872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ASL (argininosuccinate lyase) enzymatic activity is required for tumor suppression in clear cell renal cell carcinoma (ccRCC). Re-expression of ASL (with ASS1) suppresses growth in 2D, 3D, and xenograft models in an enzymatic-activity-dependent manner. ASL-mediated effects involve conservation of cellular aspartate (redirecting it away from pyrimidine synthesis) and regulation of nitric oxide synthesis.\",\n      \"method\": \"Loss-of-function (KO in HK-2 cells), gain-of-function re-expression in ccRCC lines, xenograft mouse models, metabolomic analysis, enzymatic activity mutants\",\n      \"journal\": \"Cancer & metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal assays (2D/3D growth, xenograft, metabolomics, activity-dead mutants) establishing enzymatic mechanism\",\n      \"pmids\": [\"34861885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"KLF7 transcriptionally activates ASL gene expression in glioma cells, and ASL in turn enhances polyamine biosynthesis (a urea cycle metabolite pathway), contributing to glioma cell proliferation, migration, and tumorigenesis.\",\n      \"method\": \"Transcriptional activation assays (luciferase/ChIP implied by 'transcriptionally activated'), functional knockdown/overexpression in glioma cells, polyamine metabolite measurements\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, transcriptional activation and functional cellular assays, but abstract lacks detail on mechanistic depth of ChIP/reporter\",\n      \"pmids\": [\"31018905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mutations in human adenylosuccinate lyase (ASL; EC 4.3.2.2) at positions E80D and D87E (equivalent to positions 62 and 69 in Bacillus subtilis ASL) reduce enzymatic Vmax for conversion of adenylosuccinate to AMP and fumarate and increase Km for adenylosuccinate; the D87E (position 69) mutation has modest effect while the E80D-equivalent (position 62, D→E change) causes the most drastic reduction in activity and stability, demonstrating the catalytic importance of these residues.\",\n      \"method\": \"Site-directed mutagenesis, recombinant protein expression and purification, enzyme kinetics (Vmax, Km measurements), thermal stability assay, CD spectroscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzyme reconstitution with mutagenesis and kinetic characterization in a single rigorous study\",\n      \"pmids\": [\"15471876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Cysteamine treatment of cells expressing cysteine-for-arginine ASL mutants (p.Arg94Cys, p.Arg379Cys, p.Arg385Cys) increases ASL enzymatic activity by chemically modifying the substituted cysteine to a lysine analogue, partially restoring function; p.Arg385Cys activity after cysteamine treatment resembles the designed p.Arg385Lys mutant, providing mechanistic evidence for the cysteamine action.\",\n      \"method\": \"Mammalian expression system (293T cells), transfection of ASL cysteine-for-arginine mutants, enzyme activity assay with and without cysteamine treatment\",\n      \"journal\": \"Molecular diagnosis & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based enzyme activity assay with mechanistic chemical rationale and multiple mutant comparisons, single lab\",\n      \"pmids\": [\"26745957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A missense mutation c.434A>G (p.D145G) in exon 5 of the ASL gene drives alternative splicing, causing loss of exon 5 in the mRNA, as demonstrated by exon trapping assay.\",\n      \"method\": \"Next generation sequencing, exon trapping (minigene splicing assay)\",\n      \"journal\": \"BMC medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional splicing assay (exon trapping) is a direct mechanistic experiment but single lab, single method\",\n      \"pmids\": [\"26843370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Pathogenicity of ASL splicing mutations was confirmed by functional splicing assay using a hybrid minigene. Molecular modeling using the reported 3D structure of ASL was used to predict functional consequences of missense mutations on homotetramer formation.\",\n      \"method\": \"Hybrid minigene splicing assay, molecular modeling based on ASL crystal structure, genomic DNA mutation analysis\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional splicing assay is direct experimental evidence; structural modeling is computational (Tier 4) but supports mechanistic interpretation\",\n      \"pmids\": [\"17326097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Structural analysis of ASL mutations demonstrates that pathogenic missense variants disrupt homotetramer formation by altering bonding with neighboring residues, providing a structural mechanism for ASL deficiency.\",\n      \"method\": \"Structural considerations based on published ASL homotetramer structure, mutation mapping\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Moderate — computational/structural modeling without experimental validation of tetramer disruption in this paper\",\n      \"pmids\": [\"24166829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Structural examination of four novel pathogenic ASL variants (Leu260Arg, Ser447Thr, Arg146Gly, Leu199Val) revealed that all affect stability of the tetrameric ASL structure by disturbing bonding with neighboring residues.\",\n      \"method\": \"In silico structural analysis of ASL tetramer model\",\n      \"journal\": \"Molecular genetics and metabolism reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational structural prediction only, no experimental validation of tetramer disruption\",\n      \"pmids\": [\"31709144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ASL-encoding mRNA formulated in lipid nanoparticles (LNP) produces robust ASL protein expression in vitro and in vivo, and intravenous administration in ASLNeo/Neo mice (ASLD model) drastically improves survival, demonstrating that restored ASL enzymatic activity in hepatocytes is sufficient to correct the metabolic deficit.\",\n      \"method\": \"mRNA-LNP formulation, in vitro expression in human cells, IV administration in ASLNeo/Neo mouse model, survival assay, cytokine profiling\",\n      \"journal\": \"Biomedicines\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo functional rescue with defined genetic model and multiple dose groups, single lab\",\n      \"pmids\": [\"37371829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ASL enzymatic activity is required for its tumor-suppressive function in ccRCC; catalytically inactive ASL mutants do not suppress growth, establishing that the lyase catalytic activity (cleaving argininosuccinate to arginine and fumarate) rather than a structural/scaffold role mediates growth suppression.\",\n      \"method\": \"Expression of enzymatic activity mutants in ccRCC cell lines, 2D/3D growth assays, xenograft models\",\n      \"journal\": \"Cancer & metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — activity-dead mutant rescue experiment directly tests catalytic requirement, with in vivo validation\",\n      \"pmids\": [\"34861885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Taurine suppresses urea cycle activity by targeting ASL as its main effector in hepatocellular carcinoma (HCC) cells. FOS proto-oncogene functions as a transcription factor for ASL; taurine treatment reduces FOS levels, thereby suppressing ASL expression and urea cycle activity. The FOS-ASL axis is required for the metabolic effects of taurine on HCC tumor growth.\",\n      \"method\": \"Target identification (ASL identified as taurine's main target), transcription factor analysis (FOS-ASL axis), knockdown/overexpression in HCC cell lines, metabolic assays, tumor growth assays\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — cell-based mechanistic assays with transcriptional regulation and functional rescue, but abstract lacks structural/biochemical detail of direct taurine-ASL interaction\",\n      \"pmids\": [\"41708583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The complete ASL gene structure was determined, comprising 16 coding exons, enabling systematic mutation analysis. Mutational hotspots were identified in exons 4, 5, and 7, and a predominant splicing mutation IVS5+1G→A was found on 15 alleles, establishing the genomic architecture of ASL deficiency.\",\n      \"method\": \"Genomic DNA sequencing, PCR-based mutation screening of all 16 coding exons, identification of transcript variants\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — comprehensive gene structure determination with mutation-disease correlation across 27 patients, single study\",\n      \"pmids\": [\"12384776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Novel ASL mutation c.206A>G (p.Lys69Arg) significantly reduces ASL enzymatic activity when expressed in HEK293T cells, while the p.Arg213* nonsense mutation abolishes activity entirely, confirming pathogenicity and establishing the functional importance of these residues.\",\n      \"method\": \"Expression of ASL constructs in HEK293T cells, spectrophotometric coupled enzyme assay measuring urea production\",\n      \"journal\": \"BioMed research international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct enzyme activity assay in mammalian expression system, single lab, single method\",\n      \"pmids\": [\"31183366\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Argininosuccinate lyase (ASL) is a homotetrameric enzyme that catalyzes the cleavage of argininosuccinate to arginine and fumarate, functioning both in the hepatic urea cycle (detoxifying ammonia) and in the citrulline-nitric oxide (NO) cycle in extrahepatic tissues including neurons; its catalytic activity is required for NO production via the arginine-NOS pathway, and through this mechanism ASL regulates tyrosine hydroxylase activity and catecholamine biosynthesis in locus coeruleus and substantia nigra neurons, while in cancer contexts ASL enzymatic activity controls aspartate utilization, pyrimidine biosynthesis, and nitric oxide levels to suppress tumor growth.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"Argininosuccinate lyase (ASL) is a homotetrameric urea-cycle enzyme whose lyase activity cleaves argininosuccinate to arginine and fumarate, and which serves a broader role in supplying arginine for nitric oxide (NO) production through the citrulline-NO cycle [#0, #12]. Beyond hepatic ammonia detoxification, neuronal ASL is required for brain NO homeostasis: loss of ASL produces nitrosative/oxidative stress independent of hyperammonemia, and combined hepatic plus cerebral correction normalizes NO signaling and rescues neuronal cell death and behavior [#0]. Through this NO-generating function ASL governs catecholamine biosynthesis in specific brainstem nuclei—it controls tyrosine hydroxylase abundance and activity in locus coeruleus neurons and, in substantia nigra dopaminergic neurons, restrains tyrosine aggregation and α-synuclein elevation, with NO donors rescuing the catecholamine and motor phenotypes in conditional knockouts [#1, #2]. In cancer, ASL acts as an enzymatic-activity-dependent tumor suppressor in clear cell renal cell carcinoma, where it conserves cellular aspartate away from pyrimidine synthesis and modulates NO levels; catalytically dead mutants fail to suppress growth, establishing that lyase catalysis rather than a scaffolding role is responsible [#3, #12]. ASL expression is itself transcriptionally tuned by upstream regulators, including KLF7 in glioma and a taurine-responsive FOS-ASL axis in hepatocellular carcinoma, linking ASL activity to polyamine biosynthesis and urea-cycle-driven proliferation in tumor contexts [#4, #13]. Loss-of-function mutations cause ASL deficiency: the gene comprises 16 coding exons with mutational hotspots and a predominant splicing variant, and pathogenic missense and splice mutations reduce or abolish enzymatic activity, frequently by disrupting homotetramer assembly [#14, #15, #7].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing the genomic architecture of ASL was needed to interpret disease alleles systematically; defining all 16 coding exons and recurrent mutations provided the framework for ASL deficiency genetics.\",\n      \"evidence\": \"Genomic DNA sequencing and mutation screening across 27 patients\",\n      \"pmids\": [\"12384776\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Gene structure alone does not establish functional consequence of individual variants\", \"No enzymatic or structural readout for the catalogued mutations\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"To define which residues are catalytically essential, kinetic dissection of point mutations showed specific positions are required for substrate turnover and protein stability.\",\n      \"evidence\": \"Site-directed mutagenesis, recombinant enzyme kinetics, thermal stability and CD spectroscopy\",\n      \"pmids\": [\"15471876\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Performed on a lyase-family context (adenylosuccinate lyase residues) rather than full human urea-cycle catalysis\", \"Does not address tetramer-level interactions in the cellular setting\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"To distinguish coding from splicing pathogenicity and predict missense impact, functional minigene assays plus structural mapping connected variants to tetramer disruption.\",\n      \"evidence\": \"Hybrid minigene splicing assay and molecular modeling on the ASL crystal structure\",\n      \"pmids\": [\"17326097\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural modeling is computational, not experimentally validated for tetramer disruption\", \"Single assay per variant class\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extending the structural rationale, mutation mapping argued that pathogenic missense variants disrupt homotetramer formation, offering a unifying structural mechanism for deficiency.\",\n      \"evidence\": \"Structural mapping onto the published ASL homotetramer\",\n      \"pmids\": [\"24166829\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Computational only; no experimental validation of tetramer disruption in this study\", \"Does not quantify residual enzymatic activity\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"To determine whether ASL deficiency could be chemically corrected, cysteamine was shown to chemically convert cysteine-substituted residues toward a lysine analogue and partially restore activity, providing a mechanistic rationale for pharmacochaperone-style rescue.\",\n      \"evidence\": \"Expression of cysteine-for-arginine ASL mutants in 293T cells with cysteamine treatment and activity assays\",\n      \"pmids\": [\"26745957\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab, cell-based activity readout\", \"Applies only to specific arginine-to-cysteine substitutions\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"To explain why a coding missense variant behaves as a loss-of-function allele, an exon-trapping assay revealed that c.434A>G causes exon 5 skipping, demonstrating a splicing mechanism beyond simple amino-acid change.\",\n      \"evidence\": \"Exon trapping minigene splicing assay following NGS\",\n      \"pmids\": [\"26843370\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single method, single variant\", \"No protein-level or enzymatic quantification of the resulting transcript\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Whether ASL has a brain-intrinsic role beyond hepatic ammonia clearance was unresolved; combined hepatic and cerebral gene correction established that neuronal ASL activity is required for NO homeostasis and prevents nitrosative-stress-driven neuronal death independent of hyperammonemia.\",\n      \"evidence\": \"AAV8 gene transfer in ASL-deficient mice with behavioral, biochemical, and histological readouts\",\n      \"pmids\": [\"30158522\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not map which neuronal populations require ASL most acutely\", \"NO source apportionment between cell types not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"To define a specific neuronal output of ASL-dependent NO, locus-coeruleus-specific knockout placed ASL upstream of NO-mediated regulation of tyrosine hydroxylase and catecholamine synthesis, with NO donors rescuing the phenotype.\",\n      \"evidence\": \"LC-specific conditional knockout mouse, TH activity/abundance measurements, catecholamine quantification, NO donor rescue, seizure/stress phenotyping\",\n      \"pmids\": [\"31747589\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between NO and TH abundance not fully defined\", \"Generalization to other catecholaminergic nuclei addressed only later\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"To determine whether ASL contributes to tumor biology and how, work showed KLF7 transcriptionally activates ASL in glioma and that ASL enhances polyamine biosynthesis to drive proliferation and migration.\",\n      \"evidence\": \"Transcriptional activation assays and knockdown/overexpression in glioma cells with polyamine metabolite measurement\",\n      \"pmids\": [\"31018905\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Depth of ChIP/reporter evidence for direct KLF7 binding limited\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Additional patient variants were functionally tested to confirm pathogenicity, showing p.Lys69Arg reduces and p.Arg213* abolishes enzymatic activity in a cellular system.\",\n      \"evidence\": \"Expression in HEK293T cells with spectrophotometric coupled enzyme assay measuring urea production\",\n      \"pmids\": [\"31183366\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single method, single lab\", \"No structural correlate for the activity loss\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Whether reported missense variants act through folding/assembly was addressed by in silico tetramer analysis predicting that four novel variants destabilize the tetramer.\",\n      \"evidence\": \"In silico structural analysis of the ASL tetramer model\",\n      \"pmids\": [\"31709144\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Computational prediction only, no experimental tetramer or activity validation\", \"Variant-specific residual function unquantified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"To extend the catecholaminergic role to dopaminergic neurodegeneration, conditional ASL loss in catecholamine neurons produced tyrosine aggregates, α-synuclein elevation, and motor/cognitive deficits, all rescued by NO supplementation.\",\n      \"evidence\": \"Conditional knockout mouse, immunofluorescence, catecholamine and α-synuclein measurement, NO donor rescue, behavioral testing\",\n      \"pmids\": [\"34417872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic link between NO loss and tyrosine aggregation not molecularly resolved\", \"Relevance to idiopathic Parkinsonian pathology not established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"To test whether ASL acts as a tumor suppressor through catalysis or scaffolding, re-expression with activity-dead mutants showed enzymatic activity is required for growth suppression in ccRCC, acting via aspartate conservation away from pyrimidine synthesis and NO regulation.\",\n      \"evidence\": \"Loss- and gain-of-function in ccRCC lines, xenografts, metabolomics, and catalytically inactive mutants\",\n      \"pmids\": [\"34861885\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of aspartate conservation versus NO not fully partitioned\", \"Context-specificity across tumor types not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"To establish therapeutic sufficiency of restoring ASL, mRNA-LNP delivery produced robust hepatocyte ASL expression and drastically improved survival in an ASL deficiency mouse model.\",\n      \"evidence\": \"mRNA-LNP formulation, in vitro expression, IV administration in ASLNeo/Neo mice, survival and cytokine profiling\",\n      \"pmids\": [\"37371829\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Hepatic restoration may not address cerebral NO/catecholamine phenotypes\", \"Durability and repeat-dosing tolerability not fully characterized\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"To identify how metabolic signals tune ASL in cancer, taurine was shown to act through a FOS-ASL transcriptional axis to suppress urea cycle activity and HCC tumor growth.\",\n      \"evidence\": \"Target identification, FOS-ASL transcription analysis, knockdown/overexpression in HCC lines, metabolic and tumor growth assays\",\n      \"pmids\": [\"41708583\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct physical taurine-ASL interaction not biochemically demonstrated\", \"Single mechanistic context (HCC)\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ASL-dependent NO generation is biochemically coupled to tyrosine hydroxylase abundance and tyrosine aggregation, and how its catalytic versus metabolite-channeling roles are partitioned across hepatic, neuronal, and tumor contexts, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No molecular mechanism connecting NO levels to TH protein stability\", \"No reconciliation of ASL as urea-cycle enzyme versus NO-cycle effector at the structural level\", \"Tumor-context dependence (suppressor in ccRCC, proliferative in glioma/HCC) mechanistically unexplained\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [3, 12]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [5, 15]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [8, 9, 10]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 3, 11, 13]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [3, 14, 15]}\n    ],\n    \"complexes\": [\"ASL homotetramer\"],\n    \"partners\": [\"ASS1\", \"KLF7\", \"FOS\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}